UA101501C2 - Agent for the treatment of diseases caused by pathogenic microorganisms and inflammatory processes - Google Patents

Agent for the treatment of diseases caused by pathogenic microorganisms and inflammatory processes

Info

Publication number
UA101501C2
UA101501C2 UAA201015197A UAA201015197A UA101501C2 UA 101501 C2 UA101501 C2 UA 101501C2 UA A201015197 A UAA201015197 A UA A201015197A UA A201015197 A UAA201015197 A UA A201015197A UA 101501 C2 UA101501 C2 UA 101501C2
Authority
UA
Ukraine
Prior art keywords
agent
treatment
diseases caused
pathogenic microorganisms
inflammatory processes
Prior art date
Application number
UAA201015197A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрий Ефимович Рогальский
Андрей Юрьевич Рогальский
Original Assignee
Юрий Ефимович Рогальский
Андрей Юрьевич Рогальский
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юрий Ефимович Рогальский, Андрей Юрьевич Рогальский filed Critical Юрий Ефимович Рогальский
Priority to UAA201015197A priority Critical patent/UA101501C2/en
Publication of UA101501C2 publication Critical patent/UA101501C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to medicine, in particular to an agent for the treatment of diseases caused by pathogenic microorganisms and inflammatory processes which comprises sodium metacresylate alcoholic solution and/or derivatives thereof in amount of 0.005-25% of agent weight. The agent is represented by dosage form for oral, topical and injection use.
UAA201015197A 2010-12-16 2010-12-16 Agent for the treatment of diseases caused by pathogenic microorganisms and inflammatory processes UA101501C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201015197A UA101501C2 (en) 2010-12-16 2010-12-16 Agent for the treatment of diseases caused by pathogenic microorganisms and inflammatory processes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201015197A UA101501C2 (en) 2010-12-16 2010-12-16 Agent for the treatment of diseases caused by pathogenic microorganisms and inflammatory processes

Publications (1)

Publication Number Publication Date
UA101501C2 true UA101501C2 (en) 2013-04-10

Family

ID=51950989

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201015197A UA101501C2 (en) 2010-12-16 2010-12-16 Agent for the treatment of diseases caused by pathogenic microorganisms and inflammatory processes

Country Status (1)

Country Link
UA (1) UA101501C2 (en)

Similar Documents

Publication Publication Date Title
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
HK1138840A1 (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
MX2015003653A (en) Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators.
MA33939B1 (en) 5-alkynyl-PYRIMIDINE
EA201200551A1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSED FORM, METHODS OF THEIR PRODUCTION AND APPLICATION FOR TREATMENT
MX344238B (en) Tetrazole compounds and methods of making and using same.
MX2011011854A (en) Dihydropyrimidinones for use as bace2 inhibitors.
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
MY183588A (en) New salvianolic acid compound l, preparation method and use thereof
MX2013014843A (en) Oxazepines as ion channel modulators.
IN2012DN01233A (en)
IN2012DN06720A (en)
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MX2010009623A (en) 1-benzyl-3-hydroxymethylindazoiî¹e derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1.
UA108743C2 (en) HINAZOLINE-4 (3H) -ONE DERIVATIVES FOR APPLICATION AS RI-KINASE INHIBITORS
MX342924B (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases.
MX2011009847A (en) Anthelmintic agents and their use.
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MY148948A (en) Catecholamine derivatives and prodrugs thereof
MX2011006006A (en) Compounds, pharmaceutical composition and methods for use in treating metabolic disorders.
UA104489C2 (en) Compounds for the treatment of dyslipidemia and related diseases
MX2010009625A (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40.
MX2014004858A (en) Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies.
EA201201658A1 (en) DERIVATIVES OF PIPERIDINE AND THEIR APPLICATION FOR THE TREATMENT OF METABOLIC DISORDERS
MX340985B (en) N-heteroaryl compounds.